{"id":"W2189664995","doi":"10.1007/s10549-015-3646-2","title":"A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer","year":2015,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Bone health and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society; American Society of Clinical Oncology; Amgen","keywords":"Medicine; Zoledronic acid; Breast cancer; Randomized controlled trial; Internal medicine; Bisphosphonate; Palliative care; Quality of life (healthcare); Oncology; Surgery; Cancer; Gastroenterology; Osteoporosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001374949,0.00181773,0.003613659,0.0004600826,0.0004886085,0.0009618409,0.001072187,0.002100563,0.008308161],"category_scores_gemma":[0.002244341,0.0006467011,0.001769103,0.0004630549,0.001678086,0.001141394,0.0004970651,0.003722662,0.0009827282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006318243,"about_ca_system_score_gemma":0.001312288,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009529941,"about_ca_topic_score_gemma":0.001972352,"domain_scores_codex":[0.9994666,0.0002820906,0.00002849305,0.0001035739,0.00003239783,0.00008685809],"domain_scores_gemma":[0.9986513,0.0005319339,0.0002017029,0.0001002231,0.00005601081,0.000458902],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9879333,0.003893286,0.0001237694,0.0002687692,0.0002489718,0.0000151663,0.00002585863,0.000215498,0.001483432,0.00006679616,0.0002493941,0.00547573],"study_design_scores_gemma":[0.9679988,0.03118006,0.0002563829,0.000009097821,0.0001031662,0.0000104125,0.000008261758,0.0001493348,0.0000994712,0.00007144922,0.000108893,0.000004706533],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9862257,0.003144657,0.0008532934,0.000877373,0.0007120999,0.00485525,0.001101297,0.0001448802,0.002085493],"genre_scores_gemma":[0.9832135,0.002296753,0.002507095,0.001396066,0.0005074936,0.006131681,0.001226241,0.00003003755,0.002691131],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008308161,"threshold_uncertainty_score":0.02779359,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1439251197841394,"score_gpt":0.4395517459207426,"score_spread":0.2956266261366032,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}